Carmat
André Muller graduated from the EM Lyon Business school. He brings to the board his extensive experience in the healthcare sector as CFO, director and investor.
André Muller, among others, served as Deputy Managing Director in charge of Finance at Actélion, a Swiss biotechnology company, which was acquired in 2017 by the American pharmaceutical group Johnson & Johnson.
He also contributed to the foundation of Idorsia Ltd, which he led to an IPO. The company is a spin-off of Actélion’s clinical research and development business.
This person is not in the org chart
This person is not in any offices
Carmat
CARMAT is a medical device company developing the world’s most advanced total artificial heart. CARMAT aims to eventually provide a response to a major public health issue associated with heart disease, the world’s leading cause of death: chronic and acute heart failure.